Acute Colonic Pseudo-Obstruction (ACPO / Ogilvie’s Syndrome)

Definition

Acute colonic pseudo-obstruction (ACPO) is a condition characterized by massive dilatation of the colon (especially caecum and ascending colon) without any mechanical obstruction, occurring in severely ill, postoperative, or hospitalized patients.

📌 It is a functional obstruction due to autonomic dysregulation of colonic motility.


Eponym

  • Ogilvie’s syndrome
  • First described by Sir William Heneage Ogilvie (1948) in patients with retroperitoneal malignancy


Epidemiology

  • Typically occurs in:
    • Hospitalized patients
    • ICU patients
    • Postoperative patients
  • Age: Elderly (>60 years)
  • Male predominance
  • Incidence:
    • Common after orthopedic surgery, trauma, cardiac surgery, sepsis


Pathophysiology (HIGH-YIELD)

Core Mechanism

➡️ Autonomic imbalance
➡️ Parasympathetic activity (sacral plexus S2–S4)
➡️ Unopposed sympathetic tone
➡️ Colonic atony and progressive dilatation


Why caecum is most vulnerable?

  • Largest diameter
  • According to Laplace’s law:

Wall tension Radius
➡️ Caecum dilates first highest risk of ischemia and perforation


Cellular / Functional Changes

  • Acetylcholine release
  • Enteric neuronal activity
  • Smooth muscle paralysis
  • Colonic gas + fecal accumulation


Common Precipitating Factors

Medical Conditions

  • Sepsis
  • Severe electrolyte disturbances
  • Stroke, spinal cord injury
  • Parkinson’s disease
  • Dementia
  • Heart failure
  • Renal failure

Postoperative States

  • Orthopedic surgery (hip, spine)
  • Abdominal surgery
  • Cesarean section
  • Cardiac surgery

Drugs (VERY IMPORTANT )

  • Opioids
  • Anticholinergics
  • Tricyclic antidepressants
  • Antipsychotics
  • Calcium channel blockers
  • Benzodiazepines
  • Dopamine agonists

Metabolic Abnormalities

  • Hypokalemia
  • Hypomagnesemia
  • Hypocalcemia
  • Uremia


Clinical Features

Symptoms

  • Progressive abdominal distension (hallmark)
  • Abdominal discomfort or pain
  • Nausea, vomiting
  • Constipation or paradoxical diarrhea
  • Anorexia

Signs

  • Distended, tympanitic abdomen
  • Bowel sounds:
    • Normal, reduced, or absent
  • Mild tenderness (severe pain suspect ischemia/perforation)
  • Fever, tachycardia complications

📌 Peritonitis = late & ominous sign


Differential Diagnosis 

Condition

Key Difference

Mechanical large bowel obstruction

Transition point on imaging

Volvulus

Coffee-bean sign, torsion

Toxic megacolon

Systemic toxicity + colitis

Paralytic ileus

Small + large bowel dilatation

Hirschsprung’s disease

Pediatric, chronic


Diagnosis

Laboratory Tests

  • Usually nonspecific
  • Evaluate:
    • Electrolytes (K, Mg, Ca)
    • Renal function
    • Sepsis markers
    • Lactate (ischemia)


Imaging 

Plain Abdominal X-ray

  • Colonic dilatation
  • Predominantly caecum + ascending colon
  • No air-fluid levels typical of obstruction

📌 Caecal diameter is CRITICAL

Caecal Diameter

Interpretation

< 9 cm

Normal

9–12 cm

ACPO

> 12 cm

High risk of perforation

> 14 cm

Imminent perforation


CT Abdomen with Contrast (Gold Standard)

  • Excludes mechanical obstruction
  • Uniform colonic dilatation
  • No transition point
  • Assesses ischemia, perforation

📌 CT is mandatory before pharmacologic therapy


Complications

  • Caecal ischemia
  • Colonic necrosis
  • Perforation (mortality up to 40%)
  • Sepsis
  • Electrolyte imbalance


Management (STEPWISE – EXAM FAVORITE)


1️⃣ Conservative (Initial Management)

🔹 Indicated when:

  • Caecum < 12 cm
  • No ischemia/perforation
  • Hemodynamically stable

Measures

  • NPO
  • Nasogastric decompression
  • Rectal tube
  • Stop precipitating drugs
  • Correct electrolytes
  • Treat underlying illness
  • Mobilization
  • Frequent abdominal girth monitoring
  • Serial abdominal X-rays (every 12–24 h)

📌 Success rate: ~70% within 48–72 h


2️⃣ Pharmacologic Therapy – Neostigmine

Indications

  • Failure of conservative therapy (48–72 h)
  • Caecal diameter ≥ 10–12 cm
  • No perforation or ischemia


Drug of Choice: NEOSTIGMINE

Parameter

Details

Class

Acetylcholinesterase inhibitor

Action

Acetylcholine colonic motility

Setting

ICU

Monitoring

Continuous ECG

📌 Response usually within 30 minutes


Contraindications 

  • Mechanical bowel obstruction
  • Bowel perforation
  • Ischemic colitis
  • Severe bradycardia
  • Recent MI
  • Asthma
  • Uncontrolled arrhythmias


Adverse Effects

  • Bradycardia
  • Hypotension
  • Bronchospasm
  • Excess salivation
  • Nausea

📌 Atropine must be at bedside


Efficacy

  • Success rate: 85–90%
  • Recurrence: 20–30%

➡️ Second dose may be given after 24 h if partial response


3️⃣ Colonoscopic Decompression

Indications

  • Failed neostigmine
  • Contraindication to neostigmine
  • Rapid decompression needed

Procedure

  • Flexible sigmoidoscopy or colonoscopy
  • Decompression ± decompression tube placement

Risks

  • Perforation (2–3%)
  • Bleeding
  • Recurrence

📌 Preferred over surgery when feasible


4️⃣ Surgical Management 

Indications

  • Perforation
  • Ischemia
  • Peritonitis
  • Failure of all other measures

Options

  • Cecostomy
  • Segmental colectomy
  • Subtotal colectomy

📌 Mortality extremely high in critically ill patients


Prognosis

  • Overall mortality: 10–15%
  • With perforation: 30–40%
  • Early diagnosis dramatically improves outcomes


Special ICU Considerations

  • Avoid excessive opioids
  • Aggressive electrolyte correction
  • Early mobilization
  • Vigilant abdominal monitoring
  • Multidisciplinary care (ICU + GI + Surgery)


ACPO vs Paralytic Ileus 

Feature

ACPO

Paralytic Ileus

Bowel involved

Colon only

Small + large

Caecal dilation

Marked

Mild

Autonomic cause

Yes

Postoperative

Neostigmine response

Excellent

Poor

Perforation risk

High

Low